NEW YORK – CareDx and Stanford University on Wednesday filed a patent infringement lawsuit against TAI Diagnostics in the United States District Court for the District of Delaware, alleging that TAI's heart transplant rejection test MyTAIHeart infringes on a patent owned by Stanford and exclusively licensed to CareDx covering a method for the non-invasive diagnosis of transplant rejection.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.